ANTIBODIES TARGETING LIV-1 AND USES THEREOF

Abstract: provided are antibodies and fragments thereof having binding specificity to the liver receptor homolog 1 (liv-1, slc39a6 or zip6) protein as well as their derivatives and uses.

Inventor(s): Runsheng Li, Wentao Huang, Ying Qin Zang, Zhifang LIU, Yifan Li

CPC Classification: A61K47/68031 ({Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates})

Search for rejections for patent application number 20250186601